University of Pittsburgh School of Medicine

What University of Pittsburgh School of Medicine does

The University of Pittsburgh School of Medicine, established in 1886 and operating as a public state-related academic unit of the University of Pittsburgh, provides medical education and biomedical research services with operational integration into the UPMC hospital system across Pennsylvania. It offers MD, doctoral, master's, and certificate programs through its Medical Scientist Training Program, serves 1,345 full- and part-time students, and employs 2,923 faculty members across basic and clinical science departments. The school consistently ranks as Tier 1 in U.S. News & World Report's Best Medical Schools for Research and #8 nationally in research funding ($555 million annually per Blue Ridge Institute for Medical Research, 2025).

The school's research portfolio spans more than a dozen centers and institutes, including UPMC Hillman Cancer Center, McGowan Institute for Regenerative Medicine, Magee-Womens Research Institute, the Drug Discovery Institute, and the newly launched Trivedi Institute for Space and Global Biomedicine. Core technology infrastructure encompasses next-generation sequencing diagnostics (BiliSeq), digital pathology and computational AI (CPACE), genomic surveillance (EDS-HAT), wearable fetal monitoring (OMEGA), and a multiomics AI platform (GAINMED). Recently launched AI and industry partnerships include a $10 million Leidos-funded Computational Pathology and AI Center of Excellence, a Vizzhy/Illumina-enabled GAINMED platform, and a $25 million Trivedi Family Foundation gift establishing the Space and Global Biomedicine Institute led by former NASA astronaut Kate Rubins.

Revenue mechanics span tuition from medical and graduate students, approximately $555 million in annual research grants (NIH, NSF, ARPA-H, and other federal sources), clinical care revenue generated through UPMC faculty practice, philanthropy and endowments, technology licensing and royalties, and pro-rated tuition from the international visiting student program ($4,500 per 4-week clinical elective). The school operates a hybrid go-to-market mixing institutional research collaborations, industry partnerships, and traditional academic admissions (AMCAS and NRMP), with clinical training distributed through UPMC's hospital network across Pennsylvania.

Name

University of Pittsburgh School of Medicine

Legal name

University of Pittsburgh School of Medicine

Website

https://medschool.pitt.edu

Company type

Private

Founded year

1886

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

The University of Pittsburgh School of Medicine is a public medical school founded in 1886 that delivers MD, doctoral, and master's education to 1,345 students, employs 2,923 faculty, and conducts $555 million in annual biomedical research integrated with the UPMC hospital system.

Ownership category

akta.pro rank

Product category

Medical Education and Biomedical Research

NAICS

Colleges, Universities, and Professional Schools (6113)

SIC

Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Medical Schools (MD/DO Granting) (EDAHAGAB)

akta.pro secondary industries

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC), Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Medical education
• Biomedical research
• Residency training
• Clinical research
• Graduate medical training

Headquarters

HQ city

Pittsburgh

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Education Programs: Tuition and fees from MD, PhD, master's, and certificate programs for medical students and graduate students.
2. Research Grants and Sponsored Programs: Federal and state research funding from agencies including NIH, NSF, and ARPA-H supporting biomedical research.
3. International Visiting Student Program: Pro-rated tuition of $4,500 per clinical elective for international medical students completing final year clinical training.
4. Clinical Care Revenue: Faculty physicians provide clinical services through UPMC hospitals and facilities, generating healthcare revenue.
5. Philanthropy and Endowments: Donations from alumni, foundations, and philanthropists supporting research initiatives and endowed positions.
6. Technology Commercialization: Licensing of medical technologies, patents, and innovations developed through research to healthcare industry partners.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

The University of Pittsburgh School of Medicine provides undergraduate medical education (MD degree), graduate biomedical science education (PhD and master's programs), residency and fellowship training, postdoctoral education, and conducts basic, translational, and clinical biomedical research across 40+ departments and 13 specialized research institutes. Faculty physicians provide clinical care through the affiliated UPMC hospital network, and the school licenses proprietary diagnostic technologies, AI platforms, and medical devices developed through its research programs.

Product overview

The University of Pittsburgh School of Medicine offers a portfolio of diagnostic tests, AI-powered health technology platforms, and research services. Core products include BiliSeq (a molecular diagnostic test for bile duct cancer detection), GAINMED (an AI-driven multiomics medicine platform), OMEGA (a wearable fetal monitoring system), CPACE (Computational Pathology and AI Center of Excellence for disease detection), Pitt-Vizzhy Longevity Labs (multiomics laboratory services), and EDS-HAT (a genomic sequencing-based outbreak detection system). These products span diagnostic testing services, AI/machine learning platforms for healthcare, and research infrastructure, reflecting Pitt's integration of clinical care with academic research excellence.

Differentiator

Problem solved

Functional benefit

Brands

• UPMC Hillman Cancer Center: Comprehensive cancer research and treatment center
• McGowan Institute for Regenerative Medicine
• Magee-Womens Research Institute
• Trivedi Institute for Space and Global Biomedicine
• Computational Pathology and AI Center of Excellence (CPACE)

Products and services

• Doctor of Medicine (MD) Program Four-year medical degree program for prospective physicians, with admissions through AMCAS and holistic review; graduates 174 MD degrees annually with residency placements across 25 states.
• Graduate Biomedical Science Programs (PhD and Master's) PhD and master's degree programs in biomedical sciences and graduate studies, with 70 doctoral degrees and 113 master's degrees awarded in 2026 across graduate studies departments.
• International Visiting Student Program Clinical elective program for final-year international medical students, with pro-rated tuition of $4,500 per 4-week elective; applications through VSLO or paper.
• Residency and Fellowship Training Programs Postgraduate physician training through NRMP matching, with fellowship programs across all medical specialties.
• Postdoctoral Education Program Academic Career Development program providing postdoctoral training and career development for biomedical research scholars.
• Medical Scientist Training Program (MSTP) Combined MD-PhD physician-scientist training program for students pursuing careers as physician-scientists.
• Clinical Care Services through UPMC Network Faculty physicians provide clinical services through UPMC hospitals, cancer centers, and medical facilities across Pennsylvania, including UPMC Hillman Cancer Center and UPMC Magee-Womens Hospital.
• BiliSeq Molecular Diagnostic Test DNA/RNA-based next-generation sequencing panel for detecting bile duct cancer, achieving 82% sensitivity and 98% specificity compared to 44% sensitivity for standard pathology alone.
• GAINMED AI Platform Generative and Agentic Intelligence Navigated Multiomics Medicine platform integrating genomic, metabolomic, proteomic, lipidomic, transcriptomic, microbiomic, epigenomic, and pharmacogenomic data with AI for P5 medicine (predictive, preventive, personalized, precision, and participatory care). Phase 1 recruiting 20,000 participants and 200-300 primary care providers worldwide.
• OMEGA Fetal Monitoring System Optical, Mechanical and Electrical Global Assessment of fetal hypoxia wearable monitoring system being developed to give labor and delivery teams real-time fetal health assessment, distinguishing true distress from false alarms to reduce unnecessary C-sections.
• CPACE (Computational Pathology and AI Center of Excellence) Research center developing AI-powered tools for quicker detection of diseases including heart disease and cancer through digital pathology, reducing diagnostic turnaround times with nearly 90% accuracy in cardiovascular disease prediction.
• Pitt-Vizzhy Longevity Labs Multiomics laboratory services partnership with Vizzhy Inc. and Illumina, Inc., providing multiomics laboratory services to expand precision medicine across the United States and globally with a goal of sequencing 1 million people over five years.
• EDS-HAT Outbreak Detection System Enhanced Detection System for Healthcare-Associated Transmission using genomic sequencing and machine learning to analyze infectious disease samples and detect near-identical strains of infection between patients to prevent hospital outbreaks; achieved 3.2-fold ROI with $700,000 cost savings at UPMC Presbyterian.
• Trivedi Institute for Space and Global Biomedicine Research institute focused on applying insights from spaceflight to improve human health on Earth, including technologies for resource-constrained environments. Established with $25 million founding gift from the Trivedi Family Foundation and led by former NASA astronaut Kate Rubins.
• Biomedical Research Services Basic, translational, and clinical biomedical research across 40+ departments and 13 specialized institutes (Aging Institute, Alzheimer Disease Research Center, Asthma Institute, Center for Vaccine Research, Drug Discovery Institute, McGowan Institute for Regenerative Medicine, etc.) with $555 million in annual research funding.
• Technology Transfer and Licensing Services Commercialization of medical technologies, patents, and innovations developed through research to healthcare industry partners through licensing agreements with biotechnology and pharmaceutical companies.

Quantifiable outcome

• 82% sensitivity and 98% specificity for bile duct cancer detection with BiliSeq
• +6 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature6 records

Partnerships

18 partnerships are on record, tiered flagship, core and minor.

• Kate RubinsflagshipOthers · 1 October 2025Former NASA astronaut and geneticist joined Pitt as professor of computational and systems biology and leads the Trivedi Institute. First person to sequence DNA in space with 16-year NASA career and 300 days in space experience.
• Vizzhy Inc.flagshipStrategic or Co-development Partner · 1 May 2025Global AI partnership to transform health care through GAINMED platform for generative and agentic intelligence navigated multiomics medicine. Vizzhy chose Pitt for Shekhar's vision for precision medicine. Pitt-Vizzhy Longevity Labs being established with Illumina.
• Illumina, Inc.flagshipStrategic or Co-development Partner · 1 May 2025Partner in Pitt-Vizzhy Longevity Labs providing multiomics laboratory services to expand precision medicine across the United States and globally.
• Carnegie Mellon UniversitycoreStrategic or Co-development PartnerCollaborating with CMU on the Trivedi Institute to build a global cross-institutional research and training ecosystem. CMU provides complementary strengths in AI, computation and technology innovation. Also partner in OMEGA fetal monitoring project.
• UPMC Magee-Womens HospitalcoreStrategic or Co-development PartnerOne of the project's largest clinical testing environments for OMEGA fetal monitoring system. Supported by MWRI's robust research facility and infrastructure.
• Magee-Womens Research Institute (MWRI)coreStrategic or Co-development PartnerResearch institute collaborating on OMEGA project providing clinical research capacity and infrastructure for fetal monitoring technology development.
• Children's Hospital of PhiladelphiacoreStrategic or Co-development PartnerTiffany Ko codirects the OMEGA project; CHOP is partner in multi-institution team developing fetal monitoring technology.
• University of Notre DameminorStrategic or Co-development PartnerPartner institution in OMEGA project team for fetal monitoring system development.
• Washington University in St. LouisminorStrategic or Co-development PartnerPartner institution in OMEGA project team for fetal monitoring system development.
• University of PennsylvaniaminorStrategic or Co-development PartnerPartner institution in OMEGA project team for fetal monitoring system development.
• Institute of Photonic Sciences (Barcelona, Spain)minorStrategic or Co-development PartnerInternational partner institution in OMEGA project team for fetal monitoring system development.
• Tyndall National Institute (Cork, Ireland)minorStrategic or Co-development PartnerInternational partner institution in OMEGA project team for fetal monitoring system development.
• Gladstone InstitutescoreStrategic or Co-development PartnerPart of tri-institutional CAPT-CEP network for phage research, with complementary phage research centers at Stanford University and University of Pittsburgh. Gladstone launched Center for PhAIge Therapy.
• Stanford UniversitycoreStrategic or Co-development PartnerPart of tri-institutional CAPT-CEP network for phage research alongside Gladstone Institutes and University of Pittsburgh.
• UPMCflagshipStrategic or Co-development PartnerOne of the nation's most successful examples of a health care system partnered with a medical school. Drives circular bond from research to clinical care and back to research. Faculty physicians provide clinical services through UPMC network.
• Carnegie Mellon UniversitycoreStrategic or Co-development PartnerJoint Center for the Neural Basis of Cognition between Pitt and CMU, established 1994. Strick served as codirector and later founding director of Systems Neuroscience Center.
• Global Research PartnersflagshipStrategic or Co-development PartnerGAINMED initiative aims to recruit 20,000 participants and 200-300 primary care providers worldwide to sequence samples and build knowledgebase. Pitt-Vizzhy Longevity Labs expanding to Europe and Asia.
• Carnegie Mellon UniversitycoreStrategic or Co-development PartnerJoint development of EDS-HAT system with CMU researchers. Machine learning algorithm developed jointly to detect hospital-acquired infection outbreaks.

Scale indicators26 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Columbia University Vagelos College of Physicians and Surgeons: Ivy League MD-granting medical school in New York with strong biomedical research funding and a major affiliated academic medical center (NewYork-Presbyterian). Competes with Pitt for biomedical research funding and top-tier MD applicants in the Northeast.
• UCSF School of Medicine: Premier public U.S. research medical school consistently ranked in the top 5 for NIH funding, with a major affiliated academic medical center (UCSF Health). Closest structural analog to Pitt as a top public, research-intensive medical school.
• Harvard Medical School: Largest and best-resourced U.S. MD-granting medical school, anchored by a network of Harvard-affiliated teaching hospitals. Competes globally for top faculty, NIH funding, and MD/PhD applicants, and sets the benchmark Pitt benchmarks itself against for research output.
• Stanford University School of Medicine: Top U.S. research medical school with deep industry and Silicon Valley ties, heavy investment in AI/computational biology and biomedical engineering. A direct peer in the AI/biomedicine space where Pitt is also investing (GAINMED, CPACE).
• Yale School of Medicine: Top U.S. research medical school with strong NIH funding and Yale New Haven Hospital as its primary teaching affiliate. Comparable in scale of research portfolio, MD/PhD training programs, and clinical-translation pipeline.
• Duke University School of Medicine: Top private U.S. research medical school with substantial NIH funding and a Duke University Health System integration analogous to the Pitt–UPMC model. Competes for federal grants, MD/PhD applicants, and clinical-translation partnerships.
• Washington University School of Medicine in St. Louis: Top-ranked U.S. research medical school with very high NIH funding per faculty and a strong record of clinical translation. Competes head-to-head with Pitt for federal research dollars, MD/PhD applicants, and biotech industry partnerships.
• Johns Hopkins University School of Medicine: Top-tier U.S. research medical school granting the MD degree, with comparable NIH funding scale, large biomedical research portfolio, and a flagship affiliated academic medical center (Johns Hopkins Hospital). Directly competes with Pitt for research funding, faculty recruits, and MD applicants.
• Weill Cornell Medicine: Ivy League MD-granting research medical school in New York with substantial NIH funding and tight integration with NewYork-Presbyterian. Direct comparator for the Pitt–UPMC model of academic medicine partnership with a major hospital system.
• Perelman School of Medicine at the University of Pennsylvania: Ivy League MD-granting research medical school in Pennsylvania with a top-tier NIH funding rank and a tightly integrated academic medical center (Penn Medicine). A direct in-state competitor for faculty, students, and clinical research partnerships, including with industry sponsors active in Pittsburgh.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/pitthealthsci
• Facebookfacebook.com/PittMedicine
• LinkedInlinkedin.com/school/3463/admin/feed/posts
• Instagraminstagram.com/pittmedicine

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of Pittsburgh School of Medicine